Search results
FDA approves Pfizer's 1st gene therapy
Becker’s Hospital Review· 1 day ago"Discover Pfizer's groundbreaking gene therapy, Beqvez, now FDA-approved for treating hemophilia B. Learn about its effectiveness and high price tag."
Better Buy: Pfizer vs. Viking Therapeutics
Motley Fool via Yahoo Finance· 7 days agoAt the same time, several big pharma companies continue to offer attractive valuations and dividend yields. Image Source: Getty Images. Pfizer (NYSE:...
The Motley Fool: Pfizer offers a pfat 6.4% dividend
Dallas Morning News· 2 days agoShares of Pfizer were recently down more than 35% over the past year — in part because the market’s enthusiasm for its COVID-19 vaccine Comirnaty and...
Pfizer hemophilia gene therapy arrives in US to uncertain future
BioPharma Dive via Yahoo Finance· 4 days agoDive Brief: The Food and Drug Administration on Friday approved a new gene therapy for hemophilia,...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters via AOL· 4 days ago(Reuters) -The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on...
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Benzinga via Yahoo Finance· 4 days agoFriday, the FDA approved Pfizer Inc’s (NYSE:PFE) Beqvez (fidanacogene elaparvovec-dzkt) for moderate...
Pfizer’s first gene therapy gets approval for clotting disorder
San Francisco Chronicle· 4 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine that has proved to be a challenging business. The treatment, called Beqvez ...
FDA approves Pfizer's first gene therapy for rare inherited bleeding disorder
NBC Philadelphia· 4 days agoThe Food and Drug Administration approved Pfizer's treatment for a rare genetic bleeding disorder,...
Moderna Faces Pfizer, BioNTech in London Patent Battle over Covid-19 Vaccines In Legal Showdown -...
Benzinga· 7 days agoModerna Inc. MRNA is set to clash with Pfizer Inc. PFE and BioNTech SE BNTX in a pivotal London...
Pfizer's Options: A Look at What the Big Money is Thinking - Pfizer (NYSE:PFE)
Benzinga· 4 days agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Pfizer PFE , and it's something market players shouldn't ignore. Our tracking of public ...
